Grandfield & Dodd, LLC Exact Sciences Corp Transaction History
Grandfield & Dodd, LLC
- $1.53 Billion
- Q4 2024
A detailed history of Grandfield & Dodd, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 108,961 shares of EXAS stock, worth $6.08 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
108,961
Previous 103,999
4.77%
Holding current value
$6.08 Million
Previous $7.08 Million
13.54%
% of portfolio
0.4%
Previous 0.45%
Shares
5 transactions
Others Institutions Holding EXAS
# of Institutions
661Shares Held
161MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$991 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$884 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$799 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$673 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$373 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.87B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...